| 000 | 01804 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513190802.0 | ||
| 264 | 0 | _c19990817 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0735-1097 | ||
| 024 | 7 |
_a10.1016/s0735-1097(99)00195-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRabah, M | |
| 245 | 0 | 0 |
_aHeparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention. _h[electronic resource] |
| 260 |
_bJournal of the American College of Cardiology _cAug 1999 |
||
| 300 |
_a461-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngioplasty, Balloon, Coronary _xadverse effects |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAtherectomy, Coronary _xadverse effects |
| 650 | 0 | 4 |
_aBlood Vessels _xinjuries |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xetiology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aWhole Blood Coagulation Time |
| 700 | 1 | _aMason, D | |
| 700 | 1 | _aMuller, D W | |
| 700 | 1 | _aHundley, R | |
| 700 | 1 | _aKugelmass, A D | |
| 700 | 1 | _aWeiner, B | |
| 700 | 1 | _aCannon, L | |
| 700 | 1 | _aO'Neill, W W | |
| 700 | 1 | _aSafian, R D | |
| 773 | 0 |
_tJournal of the American College of Cardiology _gvol. 34 _gno. 2 _gp. 461-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0735-1097(99)00195-3 _zAvailable from publisher's website |
| 999 |
_c10397919 _d10397919 |
||